COST EFFECTIVENESS ANALYSIS;
DECISION MAKING;
DRUG INDUSTRY;
ECONOMIC EVALUATION;
FUNDING;
HEALTH CARE COST;
HEALTH SERVICE;
HUMAN;
PRIORITY JOURNAL;
REIMBURSEMENT;
REVIEW;
DECISION MAKING;
DECISION SUPPORT TECHNIQUES;
HEALTH CARE RATIONING;
HEALTH RESOURCES;
INSURANCE, HEALTH, REIMBURSEMENT;
MODELS, ECONOMIC;
Guide to the methods of technology appraisal online
Available from URL: Accessed Mar 2
National Institute for Health and Clinical Excellence (NICE). Guide to the methods of technology appraisal [online]. Available from URL: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008pdf [Accessed 2011 Mar 2]
Pharmaceutical Benefits Advisory Committee. Guidelines for preparing submissions to the PBAC [online]. Available from URL: http://www.health.gov.au/ internet/main/publishing. nsf/content/pbacguidelines-index [Accessed 2011 Mar 2]
Modelling in economic evaluation: An unavoidable fact of life
DOI 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W
Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6: 217-27 (Pubitemid 27296586)
Assessing quality in decision analytic cost-effectiveness models: A suggested framework and example of application
Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application. Pharmacoeconomics 2000; 17 (5): 461-77 (Pubitemid 30398805)
The assessment of pharmaceuticals for government subsidy in Australia: Recent developments
Scuffham PA. The assessment of pharmaceuticals for government subsidy in Australia: recent developments. J Med Econ 2007; 10: 163-9 (Pubitemid 47067659)
Review of guidelines for good practice in decision-analytic modelling in health technology assessment
iii-iv ix-xi
Philips Z, Ginnelly L, Sculpher M, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004; 8 (36): iii-iv, ix-xi, 1-158
